The vaccine for COVID-19 the disease caused by the novel coronavirus is coming closer to reality. The University of Oxford and AstraZeneca Plc.’s promising COVID-19 vaccine is already in the final stages of clinical trials. The ChAdOx1 nCoV-19 vaccine also known as AZD1222 will be given to 10260 adults and children in the next stage in the UK. The vaccine is already being tested in volunteers in South Africa and Brazil to assess how well it works in protecting people from becoming infected with the SARS-CoV-2 virus. Project leader professor Adrian Hill the director of the Jenner Institute at the